A new study discovered that blocking a receptor in the brain that regulates immune cells could prevent some changes to memory and behaviour observed in Alzheimer’s disease. This study adds to evidence that inflammation in the brain plays a role in the development of Alzheimer’s disease
The Dementia Discovery Fund, established last year with support from the U.K. government and several of the world’s largest pharmaceutical companies, aims to create at least one breakthrough dementia treatment by 2025. The fund has made its first investment of $29.5 million to San Francisco-based Alector LLC.
A recent study revealed that cerebrovascular disease is a key determinant of psychosis in people with Alzheimer’s disease. Cerebrovascular disease is a set of conditions that constrict blood flow to the brain.